Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app ease the emotional toll of breast cancer?

NCT ID NCT07835698

Symptom relief Sponsor: National Health Research Institutes, Taiwan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Breast cancer treatment often leaves survivors with lasting anxiety, low mood, and stress. Researchers are testing an 8-week internet-based cognitive behavioral therapy program, delivered through a mobile app, to see whether it improves psychological adjustment and quality of life. About 100 adults who finished primary treatment for stage I to III breast cancer join the study. Half receive the app program alongside their usual care, and half receive usual care alone. The study compares changes in distress, depressive symptoms, post-traumatic stress symptoms, and quality of life between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an 8-week internet-based cognitive behavioral therapy program delivered through a mobile app
What this could lead to
If the program helps, it could offer breast cancer survivors a convenient, at-home way to manage anxiety, depression, and stress after treatment.
What could go wrong
This is a small study of 100 people, and app-based therapy does not work for everyone. Participants may not stick with the program, and the results may not apply to other cancer types or to people who are not comfortable with technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-65 years. * Diagnosis of stage I-III breast cancer. * Completion of primary breast cancer treatment, including surgery, chemotherapy, radiation therapy, and/or targeted therapy. Participants currently receiving endocrine therapy are eligible. * Ability to read and write Chinese and to use a mobile application and the Internet. * Access to an Internet-enabled device and ability to independently participate in the online intervention. * Willingness to complete the online intervention modules and study assessment questionnaires. Exclusion Criteria: * Diagnosis of stage IV breast cancer. * Concurrent diagnosis of another type of cancer. * Currently receiving surgery, chemotherapy, radiation therapy, or targeted therapy for breast cancer. * Diagnosis of a psychiatric disorder within the past 6 months, including major depressive disorder, generalized anxiety disorder, or schizophrenia. * No current psychiatric diagnosis but a Patient Health Questionnaire-9 (PHQ-9) score greater than 20 at screening. * Current suicidal intent or a history of actual self-harm behavior. * Currently receiving another form of psychotherapy or having recently received cognitive behavioral therapy. * Inability to independently use the online intervention application because of insufficient Chinese literacy, Internet proficiency, or access to an Internet-enabled device.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Psychological distress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.